Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Diseases and Immunity, Liver Disease Diagnosis and Treatment, Pediatric Hepatobiliary Diseases and Treatments, and Gallbladder and Bile Duct Disorders.
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis.
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease.
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
Trends in Primary Biliary Cholangitis: Prospective Cohort Study From the European Reference Network Registry (R-LIVER).
Quality Measures to Enhance the Management and Treatment of Primary Biliary Cholangitis: A Delphi Consensus Study
Diagnosing Autoimmune Hepatitis: Histological Correlations and Emerging Technologies.
Noninvasive Assessment of Portal Hypertension in Patients With Primary Biliary Cholangitis Is Affected by Severity of Cholestasis.
Fibrate-Oca (FI-OCA) Study - a Global snapshot of PBC practice around the Globe
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives
Improving Primary Biliary Cholangitis Outcomes in the Evolving Landscape of Second-Line Therapies.
Quality Measures to Enhance the Management and Treatment of Primary Biliary Cholangitis: A Delphi Consensus Study.
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis
Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis.
Noninvasive Assessment of Portal Hypertension in Patients With Primary Biliary Cholangitis Is Affected by Severity of Cholestasis
Longer transplant-free and liver-related event-free survival in obeticholic acid-treated patients with primary biliary cholangitis compared to external controls from two large real-world cohorts
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score.
Biochemical response to obeticholic acid drives liver stiffness variation over time and the risk of liver-related events in patients with primary biliary cholangitis
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?
Setanaxib, a first‐in‐class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo‐controlled, phase 2 trial
Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trial.
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement
Artificial Intelligence and liver: Opportunities and barriers
Intensive care management of acute-on-chronic liver failure
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis